Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study DOI Creative Commons
Natsuko Ishida, Ayano Katsura,

Koichi Takagaki

et al.

BMC Oral Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: Aug. 2, 2024

Hyposalivation is treated using oral cholinergic drugs; however, systemic side effects occasionally lead to discontinuation of treatment. We aimed investigate the transdermal pilocarpine on salivary gland skin saliva secretion and safety in rats. Pilocarpine was administered rats orally (0.5 mg/kg) or topically (5 mg/body). Saliva volume, number sweat dots, fecal weight were measured along with concentration plasma submandibular tissues. volume significantly increased 0.5 h after administration 0.5, 3, 12 topical administration. Fecal dots 1 administration; no changes observed application. The tissues group higher than that at application persistently without inducing sweating diarrhea. Transdermal applied over glands may be an effective safe treatment option for hyposalivation.

Language: Английский

Investigating the Effect of Capsaicin Oral Solution in the Treatment of Burning Mouth in Patients: A Randomized Clinical Trial DOI Creative Commons
Kimia Ghods, Arezoo Alaee, Arash Azizi

et al.

Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown

Published: March 31, 2025

Abstract Background Burning mouth syndrome is one of the most prevalent complications oral cavity with unclear etiology, which has led to offering inconclusive treatments. Due limited studies on effects solution form capsaicin BMS, this study was conducted aim investigating effect in treatment burning patients. Methods In double-blind clinical trial study, 22 eligible female patients suffering from were randomly divided into 2 case and control groups. group, subjects dissolved 10 drops 1 tablespoon water swished times a day for minute their 30 days. The same way consumption prescribed group that used placebo solution. Vitamin B zinc supplements also given both groups, amount assessed by visual analog scale, non-stimulating saliva determined Schirmer's test, xerostomia quality life recorded standard questionnaires days 0 intervention. Results findings research exhibited variables mouth, xerostomia, saliva, show significant difference before after intervention (p value < 0.05). However, there no prominent between groups at regarding 4 mentioned > Conclusions It concluded use twice days, along vitamin supplements, cannot improve sensation, levels compared placebo. Nonetheless, it observed all parameters slightly improved Trial registration study’s protocol followed Declaration Helsinki approved ethics committee Islamic Azad University Faculty Dentistry, Tehran, Iran (IR.IAU.DENTAL.REC.1400.155) 01/10/2022, subscribed Iranian registry trials (IRCT20220117053748N1). available https//irct.behdasht.gov.ir/trial/61360.

Language: Английский

Citations

0

Cancer treatment-related xerostomia: basics, therapeutics, and future perspectives DOI Creative Commons
Mohammad‐Salar Hosseini, Sarvin Sanaie, Ata Mahmoodpoor

et al.

European journal of medical research, Journal Year: 2024, Volume and Issue: 29(1)

Published: Nov. 30, 2024

Xerostomia, generally addressed as dry mouth, poses significant challenges to patients' quality of life, particularly in the context cancer treatment. Although various medications and interventions, including salivary substitutes stimulants, muscarinic agonists, antineoplastic detoxifying agents, anti-inflammatory superoxide dismutase mimetics, mesenchymal stem cells, submandibular gland transfer, intensity-modulated radiation therapy, dose fractionation, transcutaneous electrical nerve stimulation, hyperbaric oxygen photobiomodulation, acupuncture, nutritional have been proposed for this condition, no approved or definite treatments are currently available. Moreover, evidence supporting efficacy interventions remains limited subject controversy terms safety, efficacy, optimal protocol. This review provides a comprehensive insight into treatment-related xerostomia, underlying its pathophysiology, etiology, clinical manifestation, therapeutic options, providing guide clinicians adopt patient-tailored approach xerostomia offering vision on current ongoing future studies field.

Language: Английский

Citations

2

Dental manifestations of antitumor therapy: literature review and practical recommendations DOI Open Access
Ruslan Kazbekovich Esiev, Aminat R. Shakhabova,

Lalita V. Tsokova

et al.

Russian Journal of Dentistry, Journal Year: 2024, Volume and Issue: 28(4), P. 399 - 411

Published: July 3, 2024

Anticancer therapy is associated with a wide range of systemic symptoms, including oral pathologies, such as dry mouth, mucositis, masticatory spasm, osteoradionecrosis, dental caries, opportunistic infections, dysphagia, hypogeusia, dysgeusia, and hyposalivation. Dental professionals are the most qualified experts in diagnosis treatment well their prevention control cancer patients receiving radiation or chemotherapy. The aim review was to assess domestic international literature on primary complications anticancer therapy. also aimed highlight importance care improving quality life these patients, provide practical guidelines for managing complications. search performed using electronic databases PubMed, eLIBRARY.RU, Google Scholar. yielded 55 sources, which were included review. may result significant hyposalivation, changes taste, pain. These symptoms can affect various functions cavity oropharynx, causing mouth difficulties chewing swallowing, impairs nutrition. Moreover, they speech, hygiene, denture treatment, appearance, all be detrimental health, social emotional wellbeing. side effects reduce compliance therapy, affecting outcomes, overall costs. When examining professional must consider prescribed potential long-term similar those bisphosphonates. As result, patient will continue receive necessary any new problems identified early.

Language: Английский

Citations

0

Transdermal pilocarpine on the skin over salivary glands to increase salivation: an in vivo study DOI Creative Commons
Natsuko Ishida, Ayano Katsura,

Koichi Takagaki

et al.

BMC Oral Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: Aug. 2, 2024

Hyposalivation is treated using oral cholinergic drugs; however, systemic side effects occasionally lead to discontinuation of treatment. We aimed investigate the transdermal pilocarpine on salivary gland skin saliva secretion and safety in rats. Pilocarpine was administered rats orally (0.5 mg/kg) or topically (5 mg/body). Saliva volume, number sweat dots, fecal weight were measured along with concentration plasma submandibular tissues. volume significantly increased 0.5 h after administration 0.5, 3, 12 topical administration. Fecal dots 1 administration; no changes observed application. The tissues group higher than that at application persistently without inducing sweating diarrhea. Transdermal applied over glands may be an effective safe treatment option for hyposalivation.

Language: Английский

Citations

0